William Blair & Company’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-251,967
| Closed | -$25M | – | 1847 |
|
|
2019
Q3 | $25M | Sell |
251,967
-13,071
| -5% | -$1.24M | 0.14% | 149 |
|
|
2019
Q2 | $24.5M | Sell |
265,038
-56,887
| -18% | -$5.4M | 0.14% | 148 |
|
|
2019
Q1 | $30.4M | Sell |
321,925
-229,851
| -42% | -$20.1M | 0.19% | 118 |
|
|
2018
Q4 | $35.4M | Sell |
551,776
-159,285
| -22% | -$11.8M | 0.26% | 95 |
|
|
2018
Q3 | $63.6M | Sell |
711,061
-9,663
| -1% | -$854K | 0.39% | 64 |
|
|
2018
Q2 | $57.2M | Sell |
720,724
-5,431
| -0.7% | -$451K | 0.39% | 63 |
|
|
2018
Q1 | $64.8M | Buy |
726,155
+36,176
| +5% | +$3.47M | 0.46% | 55 |
|
|
2017
Q4 | $72M | Sell |
689,979
-28,464
| -4% | -$3.21M | 0.49% | 50 |
|
|
2017
Q3 | $105M | Sell |
718,443
-8,851
| -1% | -$1.21M | 0.79% | 27 |
|
|
2017
Q2 | $94.5M | Buy |
727,294
+26,138
| +4% | +$3.2M | 0.71% | 28 |
|
|
2017
Q1 | $86.8M | Sell |
701,156
-85,276
| -11% | -$10.2M | 0.7% | 31 |
|
|
2016
Q4 | $91M | Sell |
786,432
-35,968
| -4% | -$4.01M | 0.81% | 24 |
|
|
2016
Q3 | $86M | Buy |
822,400
+10,071
| +1% | +$1.09M | 0.76% | 27 |
|
|
2016
Q2 | $80.1M | Sell |
812,329
-54,168
| -6% | -$5.6M | 0.75% | 29 |
|
|
2016
Q1 | $86.7M | Buy |
866,497
+38,205
| +5% | +$3.93M | 0.82% | 22 |
|
|
2015
Q4 | $99.2M | Buy |
828,292
+17,131
| +2% | +$1.98M | 0.93% | 18 |
|
|
2015
Q3 | $87.7M | Buy |
811,161
+993
| +0.1% | +$123K | 0.76% | 22 |
|
|
2015
Q2 | $93.8M | Sell |
810,168
-66,992
| -8% | -$7.66M | 0.14% | 200 |
|
|
2015
Q1 | $101M | Sell |
877,160
-44,734
| -5% | -$5.35M | 0.16% | 192 |
|
|
2014
Q4 | $103M | Sell |
921,894
-15,537
| -2% | -$1.64M | 0.17% | 186 |
|
|
2014
Q3 | $88.8M | Sell |
937,431
-11,380
| -1% | -$1.03M | 0.15% | 203 |
|
|
2014
Q2 | $81.5M | Buy |
948,811
+59,715
| +7% | +$4.54M | 0.13% | 224 |
|
|
2014
Q1 | $62.1M | Buy |
889,096
+57,264
| +7% | +$4.53M | 0.1% | 279 |
|
|
2013
Q4 | $70.3M | Buy |
831,832
+27,374
| +3% | +$2.17M | 0.12% | 269 |
|
|
2013
Q3 | $62M | Sell |
804,458
-57,338
| -7% | -$4.02M | 0.11% | 274 |
|
|
2013
Q2 | $50.4M | Buy |
+861,796
| New | +$51.9M | 0.1% | 311 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
William Blair & Company's CELG Position: Q4 2019 in Review
William Blair & Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 251,967 shares — an estimated $25M sold.
William Blair & Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $105M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- William Blair & Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- William Blair & Company sold 251,967 Celgene Corp shares in Q4 2019, an estimated $25M.
- William Blair & Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- William Blair & Company's Celgene Corp position peaked at $105M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on William Blair & Company's 13F filing for Q4 2019, filed 13 Feb 2020.